Streetbeat News

Earnings

GAUZ

Gauzy has announced preliminary Q3 revenue figures between $23M and $23.5M, which fall short of the estimated $27.60M.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:29 pm

FDUS

Fidus Investment (NASDAQ:FDUS) reported Q3 2024 earnings of $0.61 per share, surpassing the $0.57 estimate, despite a year-over-year decrease. Sales also exceeded expectations at $38.382 million, marking a 12.28% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:28 pm

TNC

Tennant Company has reaffirmed its FY2024 adjusted EPS guidance at $6.15-6.55, which is slightly below the analyst estimate of $6.51. The company also reaffirmed its FY2024 sales guidance at $1.28 billion to $1.30 billion, aligning closely with the $1.29 billion analyst estimate.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:27 pm

AXTI

AXT reported a Q3 2024 GAAP EPS of $(0.07), beating the estimate of $(0.08), but sales of $23.645M missed the $25.985M estimate. EPS improved by 50% from last year, while sales increased by 36.16%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:27 pm

DORM

Dorman Products reported Q3 2024 earnings per share of $1.96, surpassing the analyst estimate of $1.53, marking a 40% increase from the previous year. However, sales of $503.773 million fell short of the $510.153 million estimate, despite a 3.19% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:26 pm

EMN

Eastman Chemical reported Q3 2024 earnings per share of $2.26, surpassing the analyst estimate of $2.14. The company's sales reached $2.46 billion, exceeding the expected $2.38 billion and marking an 8.69% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:26 pm

MRIN

Marin Software projects its Q4 sales to be between $4.000 million and $4.200 million.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:26 pm

FOXF

Fox Factory shares declined following the release of disappointing Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:26 pm

HALO

Halozyme Therapeutics shares rose following the release of strong Q3 financial results and an optimistic FY24 adjusted EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:24 pm

TEAM

Atlassian Corp (NASDAQ:TEAM) reported strong fiscal Q1 results, beating both revenue and EPS estimates. The company highlighted its focus on AI with the launch of a new product, Rovo. Atlassian's shares rose significantly in after-hours trading.

Portfolio Pulse from Adam Eckert

October 31, 2024 | 8:24 pm